According to the new market research report "Immunoprecipitation Market by Product (Kit, Reagent (Antibodies, Magnetic Buffer)), Type (Individual IP, CoImmunoprecipitation, CHIP), End User (Academics, Research Institutes, Pharmaceutical and Biotechnology Companies) - Global Forecast to 2024", published by MarketsandMarkets™, the market for Immunoprecipitation is expected to grow from USD 560 million in 2018 to USD 750 million by 2024, at a CAGR of 5.0% during the forecast period.
Browse in-depth TOC on "Immunoprecipitation Market"
82 – Tables
25 – Figures
113 – Pages
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=78538655
Individual IP is expected to account for the largest market share during the forecast period.
On the basis of type, the Immunoprecipitation Market is segmented into individual IP, co-IP, ChIP, and RIP. The increasing use of IP in studying protein-protein interaction, to detect the presence of an antigen, and to determine the relative quantity of an antigen are driving the use of individual IP in various research studies.
North America is expected to account for the largest market share during the forecast period.
Based on region, the Immunoprecipitation Market is broadly divided into North America, Europe, the Asia Pacific, and the RoW. In 2018, North America accounted for the largest share of the Immunoprecipitation Market. The large share of this region can be attributed to growing research in the fields of genomics and proteomics, a large number of academic and research institutes, and the strong presence of global players in this region.
Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=78538655
The prominent players in the global Immunoprecipitation Market are Thermo Fisher Scientific (US), Abcam (UK), and Merck KGaA (Germany)
Mr. Aashish Mehra
630 Dundee Road
Northbrook, IL 60062
Email: [email protected]